美国放射学会适宜性标准®:肺癌筛查
美国放射学会适宜性标准专家组基于文献分析与RAND/UCLA适宜性方法及GRADE分级,对肺癌筛查的影像检查适宜性进行评级。推荐55至80岁、吸烟史30包年及以上且目前吸烟或过去15年内戒烟者行低剂量CT筛查;不满足上述标准但有额外风险因素者行低剂量CT筛查存在争议但可能适宜;年龄小于50岁或大于80岁、吸烟史少于20包年且无额外风险因素者不推荐影像筛查。
要点
- 55至80岁、30包年及以上吸烟史且目前吸烟或戒烟不足15年者,推荐低剂量CT筛查。
- 不满足上述标准但有额外风险因素者,低剂量CT筛查存在争议但可能适宜。
- 年龄小于50岁或大于80岁、吸烟史少于20包年且无额外风险因素者,不推荐影像筛查。
核心结论
- 肺癌仍是男性和女性癌症死亡的首位原因,吸烟是肺癌发生的最重要单一风险因素;符合年龄与吸烟史标准者应行低剂量CT肺癌筛查,不符合标准但有额外风险因素者筛查存在争议但可能适宜,特定低风险人群不推荐影像筛查。
研究设计与样本
- 美国放射学会适宜性标准是由多学科专家小组每年审阅的、针对特定临床情况的循证指南;指南制定与修订包括对同行评议期刊当前医学文献的广泛分析,并应用RAND/UCLA适宜性方法和GRADE对特定临床场景下影像与治疗程序的适宜性进行评级;证据缺乏或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。
诊断标准与关键数值
- 55至80岁、吸烟史30包年及以上、目前吸烟或过去15年内戒烟者,应行低剂量CT肺癌筛查。
- 不满足上述标准但有肺癌额外风险因素者,低剂量CT肺癌筛查存在争议但可能适宜。
- 年龄小于50岁或大于80岁者,不推荐行影像肺癌筛查。
- 任何年龄、吸烟史少于20包年且无额外风险因素者,不推荐行影像肺癌筛查。
- 额外风险因素包括氡暴露、职业暴露、癌症病史、肺癌家族史、COPD病史或肺纤维化病史。
临床应用与阅片要点
- 阅片与报告时应结合患者年龄、包年吸烟史、当前吸烟状态或戒烟时间判断是否符合低剂量CT筛查标准。
- 对不符合标准但有氡暴露、职业暴露、癌症病史、肺癌家族史、COPD病史或肺纤维化病史者,低剂量CT筛查存在争议但可能适宜。
局限性
- 证据缺乏或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Lung cancer remains the leading cause of cancer death in both men and women. Smoking is the single greatest risk factor for the development of lung cancer. For patients between the age of 55 and 80 with 30 or more pack years smoking history who currently smoke or who have quit within the last 15 years should undergo lung cancer screening with low-dose CT. In patients who do not meet these criteria but who have additional risk factors for lung cancer, lung cancer screening with low-dose CT is controversial but may be appropriate. Imaging is not recommended for lung cancer screening of patient younger than 50 years of age or patients older than 80 years of age or patients of any age with less than 20 packs per year history of smoking and no additional risk factor (ie, radon exposure, occupational exposure, cancer history, family history of lung cancer, history of COPD, or history of pulmonary fibrosis). The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
引用
- Donnelly EF, Kazerooni EA, Lee E, et al. ACR Appropriateness Criteria® Lung Cancer Screening. J Am Coll Radiol. 2018. PMID: 30392603. doi:10.1016/j.jacr.2018.09.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。